SEATTLE — TwinStrand Biosciences, Inc., a next-generation DNA sequencing technology company, announced today that Gary Gilliland, M.D., Ph.D., has been appointed to its Board of Directors as the company’s fifth board member. Dr. Gilliland brings over 30 years of clinical and research leadership experience, most recently serving as president and director of the Seattle-based Fred Hutchinson Cancer Research Center […]
Proprietary in Situ Single-Cell Omics Technology Speeds Drug & Biomarker Discovery Vizgen, a life sciences company developing the next generation of in situ single-cell genomics, today announced the launch of its Pharma Accelerator Lab in response to high demand from leading pharmaceutical companies who are increasingly turning to single-cell and spatial transcriptomics solutions to accelerate […]
– ScaleReady is a joint venture between Bio-Techne, Fresenius Kabi, and Wilson Wolf – ScaleReady’s mission is to make the business of cell and gene therapy practical and viable by providing the most simple, scalable and versatile manufacturing platform in the industry – ScaleReady will provide sales, marketing, and application support for customers globally ScaleReady, a joint venture […]
With support from the Centers for Disease Control and Prevention (CDC), Illumina and Helix have already identified more than 50 cases of the new variant in the US SAN DIEGO–Illumina, Inc. (Nasdaq: ILMN) and Helix today announced a collaboration to augment national surveillance infrastructure in the US to track the emergence and prevalence of novel […]
MENLO PARK, CA LevitasBio, a life science tools leader in label-free sample enrichment for cellular analysis, today announced the closing of its $18 million Series B financing round, led by Thalys Medical and joined by Series A lead investor Decheng Capital. The company is the manufacturer of the LeviCell – the world’s first label-free […]
On January 4, 2021, Analytical BioSciences, a single-cell genomics and discovery company, launched OmniBrowser™, a comprehensively curated single cell data compendium with visualization and analysis capabilities that further empower innovative drug discovery and development. “Single cell genomics is becoming a cornerstone for drug discovery and development, clinical diagnosis and scientific research. I hope that OmniBrowser™ […]
WALTHAM, Mass. — Thermo Fisher Scientific, the world leader in serving science, today announced it has completed the acquisition of Phitonex, Inc., a Durham, North Carolina-based company that has pioneered a spectral dye platform for high-resolution biology applications designed to accelerate research and development in cell therapy, immuno-oncology and immunology research. Phitonex’s product offering will enable Thermo […]
Münster/Altenberge evorion biotechnologies GmbH is pleased to announce that it has closed a financing round with a group of new and existing investors and entered into a long-term strategic partnership with Jüke Systemtechnik GmbH. The goal of the financing round and strategic partnering is to: expand commercialization of evorion’s CellCity System as an integrated solution […]
SAN DIEGO — Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that Nasdaq has granted the Company an additional 180-day compliance period, or until June 28, 2021, to regain compliance with Nasdaq’s minimum $1.00 closing bid price per share requirement. Nasdaq’s determination is based on the Company meeting the continued listing requirement for market value of […]
TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it has received notification of the issuance of Canadian patent number 2877729 for “Nuclease Protection Methods for Detection of Nucleotide Variants.” The patented technology involves a nuclease protection method using wildtype […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
